Okamoto K - Search Results

1

Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations.

Okamoto K, Okamoto I, Okamoto W, Tanaka K, Takezawa K, Kuwata K, Yamaguchi H, Nishio K, Nakagawa K. Okamoto K, et al. Among authors: okamoto w, okamoto i. Cancer Res. 2010 Dec 15;70(24):10402-10. doi: 10.1158/0008-5472.CAN-10-2438. Cancer Res. 2010. PMID: 21159653

2

Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibition.

Okamoto W, Okamoto I, Yoshida T, Okamoto K, Takezawa K, Hatashita E, Yamada Y, Kuwata K, Arao T, Yanagihara K, Fukuoka M, Nishio K, Nakagawa K. Okamoto W, et al. Among authors: okamoto i, okamoto k. Mol Cancer Ther. 2010 May;9(5):1188-97. doi: 10.1158/1535-7163.MCT-10-0002. Epub 2010 Apr 20. Mol Cancer Ther. 2010. PMID: 20406949

3

MET tyrosine kinase inhibitor crizotinib (PF-02341066) shows differential antitumor effects in non-small cell lung cancer according to MET alterations.

Tanizaki J, Okamoto I, Okamoto K, Takezawa K, Kuwata K, Yamaguchi H, Nakagawa K. Tanizaki J, et al. Among authors: okamoto i, okamoto k. J Thorac Oncol. 2011 Oct;6(10):1624-31. doi: 10.1097/JTO.0b013e31822591e9. J Thorac Oncol. 2011. PMID: 21716144 Free article.

4

Overcoming erlotinib resistance in EGFR mutation-positive non-small cell lung cancer cells by targeting survivin.

Okamoto K, Okamoto I, Hatashita E, Kuwata K, Yamaguchi H, Kita A, Yamanaka K, Ono M, Nakagawa K. Okamoto K, et al. Among authors: okamoto i. Mol Cancer Ther. 2012 Jan;11(1):204-13. doi: 10.1158/1535-7163.MCT-11-0638. Epub 2011 Nov 10. Mol Cancer Ther. 2012. PMID: 22075159

5

Bronchoscopic findings for bevacizumab-related pulmonary hemorrhage in advanced non-small cell lung cancer.

Okamoto K, Okamoto I, Miyazaki M, Tanaka K, Kaneda H, Nakagawa K. Okamoto K, et al. Among authors: okamoto i. Invest New Drugs. 2013 Oct;31(5):1364-6. doi: 10.1007/s10637-013-9951-x. Epub 2013 Mar 24. Invest New Drugs. 2013. PMID: 23525757

6

Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR-mutated lung cancer via an EGFR signal.

Togashi Y, Hayashi H, Okamoto K, Fumita S, Terashima M, de Velasco MA, Sakai K, Fujita Y, Tomida S, Nakagawa K, Nishio K. Togashi Y, et al. Among authors: okamoto k. Lung Cancer. 2015 Apr;88(1):16-23. doi: 10.1016/j.lungcan.2015.01.027. Epub 2015 Feb 7. Lung Cancer. 2015. PMID: 25704955

7

Afatinib-refractory brain metastases from EGFR-mutant non-small-cell lung cancer successfully controlled with erlotinib: a case report.

Nonagase Y, Okamoto K, Iwasa T, Yoshida T, Tanaka K, Takeda M, Kaneda H, Shimizu T, Tsurutani J, Nakagawa K. Nonagase Y, et al. Among authors: okamoto k. Anticancer Drugs. 2016 Mar;27(3):251-3. doi: 10.1097/CAD.0000000000000317. Anticancer Drugs. 2016. PMID: 26575001

8

Progression-Free and Overall Survival of Patients With ALK Rearrangement-Positive Non-Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib.

Watanabe S, Hayashi H, Okamoto K, Fujiwara K, Hasegawa Y, Kaneda H, Tanaka K, Takeda M, Nakagawa K. Watanabe S, et al. Among authors: okamoto k. Clin Lung Cancer. 2016 Nov;17(6):528-534. doi: 10.1016/j.cllc.2016.05.001. Epub 2016 May 18. Clin Lung Cancer. 2016. PMID: 27318655

9

Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancer.

Shimizu T, Nishio K, Sakai K, Okamoto I, Okamoto K, Takeda M, Morishita M, Nakagawa K. Shimizu T, et al. Among authors: okamoto i, okamoto k. Cancer Chemother Pharmacol. 2020 Aug;86(2):211-219. doi: 10.1007/s00280-020-04112-1. Epub 2020 Jul 8. Cancer Chemother Pharmacol. 2020. PMID: 32638093 Clinical Trial.

10

Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients.

Okamoto K, Okamoto I, Takezawa K, Tachibana I, Fukuoka M, Nishimura Y, Nakagawa K. Okamoto K, et al. Among authors: okamoto i. Jpn J Clin Oncol. 2010 Jan;40(1):54-9. doi: 10.1093/jjco/hyp137. Epub 2009 Oct 16. Jpn J Clin Oncol. 2010. PMID: 19837690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,444 results

Search Page

Filters